{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,10]],"date-time":"2026-08-10T13:34:52Z","timestamp":1786368892984,"version":"build-2736575974"},"reference-count":45,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2022,9,1]],"date-time":"2022-09-01T00:00:00Z","timestamp":1661990400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,9,1]],"date-time":"2022-09-01T00:00:00Z","timestamp":1661990400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,6,8]],"date-time":"2022-06-08T00:00:00Z","timestamp":1654646400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["cell.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Molecular Therapy - Oncolytics"],"published-print":{"date-parts":[[2022,9]]},"DOI":"10.1016\/j.omto.2022.06.005","type":"journal-article","created":{"date-parts":[[2022,6,10]],"date-time":"2022-06-10T15:47:43Z","timestamp":1654876063000},"page":"141-157","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":13,"special_numbering":"C","title":["Lentiviral interferon: A novel method for gene therapy in bladder cancer"],"prefix":"10.1016","volume":"26","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-5325-5574","authenticated-orcid":false,"given":"Sharada","family":"Mokkapati","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vikram M.","family":"Narayan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ganiraju C.","family":"Manyam","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amy H.","family":"Lim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jonathan J.","family":"Duplisea","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrea","family":"Kokorovic","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tanner S.","family":"Miest","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anirban P.","family":"Mitra","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Devin","family":"Plote","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Selvalakshmi Selvaraj","family":"Anand","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael J.","family":"Metcalfe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"suffix":"Jr.","given":"Kenneth","family":"Dunner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Burles A.","family":"Johnson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bogdan A.","family":"Czerniak","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tiina","family":"Nieminen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tommi","family":"Heikura","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Seppo","family":"Yla-Herttuala","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nigel R.","family":"Parker","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kimberley S.","family":"Schluns","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David J.","family":"McConkey","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8969-711X","authenticated-orcid":false,"given":"Colin P.","family":"Dinney","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.omto.2022.06.005_bib1","first-page":"1021","article-title":"Diagnosis and treatment of non-muscle invasive bladder cancer: AUA\/SUO guideline","volume":"196","author":"Chang","year":"2016","journal-title":"J.\u00a0Urol."},{"key":"10.1016\/j.omto.2022.06.005_bib2","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1038\/nrurol.2017.16","article-title":"BCG-unresponsive non-muscle-invasive bladder cancer: recommendations from the IBCG","volume":"14","author":"Kamat","year":"2017","journal-title":"Nat. Rev. Urol."},{"key":"10.1016\/j.omto.2022.06.005_bib3","doi-asserted-by":"crossref","first-page":"516","DOI":"10.1016\/j.urolonc.2017.06.043","article-title":"Current clinical trials in non-muscle invasive bladder cancer","volume":"35","author":"Siddiqui","year":"2017","journal-title":"Urol. Oncol."},{"key":"10.1016\/j.omto.2022.06.005_bib4","doi-asserted-by":"crossref","first-page":"1595","DOI":"10.1517\/14712598.4.10.1595","article-title":"Human cancer gene therapy with cytokine gene-modified cells","volume":"4","author":"Wysocki","year":"2004","journal-title":"Expert Opin. Biol. Ther."},{"key":"10.1016\/j.omto.2022.06.005_bib5","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1016\/j.ymthe.2020.10.022","article-title":"Clinical perspective: treatment of aggressive B cell lymphomas with FDA-approved CAR-T cell Therapies","volume":"29","author":"Leick","year":"2020","journal-title":"Mol. Ther."},{"key":"10.1016\/j.omto.2022.06.005_bib6","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1038\/sj.gt.3301348","article-title":"Identification of polyamides that enhance adenovirus-mediated gene expression in the urothelium","volume":"8","author":"Connor","year":"2001","journal-title":"Gene Ther."},{"key":"10.1016\/j.omto.2022.06.005_bib7","first-page":"850","article-title":"Phase I trial of intravesical recombinant adenovirus mediated interferon-\u03b12b formulated in Syn3 for Bacillus calmette-gu\u00e9rin failures in nonmuscle invasive bladder cancer","volume":"190","author":"Dinney","year":"2013","journal-title":"J.\u00a0Urol."},{"key":"10.1016\/j.omto.2022.06.005_bib8","doi-asserted-by":"crossref","first-page":"3410","DOI":"10.1200\/JCO.2017.72.3064","article-title":"Intravesical rAd\u2013IFN\u03b1\/syn3 for patients with high-grade, Bacillus calmette-guerin\u2013refractory or relapsed non\u2013muscle-invasive bladder cancer: a phase II randomized study","volume":"35","author":"Shore","year":"2017","journal-title":"J.\u00a0Clin. Oncol."},{"key":"10.1016\/j.omto.2022.06.005_bib9","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1016\/S1470-2045(20)30540-4","article-title":"Intravesical nadofaragene firadenovec gene therapy for BCG-unresponsive non-muscle-invasive bladder cancer: a single-arm, open-label, repeat-dose clinical trial","volume":"22","author":"Boorjian","year":"2020","journal-title":"Lancet Oncol."},{"key":"10.1016\/j.omto.2022.06.005_bib10","doi-asserted-by":"crossref","first-page":"1635","DOI":"10.1016\/j.urolonc.2012.04.010","article-title":"Intravesical valrubicin in patients with bladder carcinoma in\u00a0situ and contraindication to or failure after bacillus Calmette-Gu\u00e9rin","volume":"31","author":"Dinney","year":"2013","journal-title":"Urol. Oncol."},{"key":"10.1016\/j.omto.2022.06.005_bib11","doi-asserted-by":"crossref","first-page":"919","DOI":"10.1016\/S1470-2045(21)00147-9","article-title":"Pembrolizumab monotherapy for the treatment of high-risk non-muscle-invasive bladder cancer unresponsive to BCG (KEYNOTE-057): an open-label, single-arm, multicentre, phase 2 study","volume":"22","author":"Balar","year":"2021","journal-title":"Lancet Oncol."},{"key":"10.1016\/j.omto.2022.06.005_bib12","doi-asserted-by":"crossref","first-page":"872","DOI":"10.4161\/cbt.6.6.4088","article-title":"Interferon-alpha induces TRAIL expression and cell death via an IRF-1-dependent mechanism in human bladder cancer cells","volume":"6","author":"Papageorgiou","year":"2007","journal-title":"Cancer Biol. Ther."},{"key":"10.1016\/j.omto.2022.06.005_bib13","first-page":"808","article-title":"Inhibition of basic fibroblast growth factor expression, angiogenesis, and growth of human bladder carcinoma in mice by systemic interferon-alpha administration","volume":"58","author":"Dinney","year":"1998","journal-title":"Cancer Res."},{"key":"10.1016\/j.omto.2022.06.005_bib14","first-page":"1258","article-title":"Inhibition of tumorigenicity and metastasis of human bladder cancer growing in athymic mice by interferon-beta gene therapy results partially from various antiangiogenic effects including endothelial cell apoptosis","volume":"8","author":"Izawa","year":"2002","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.omto.2022.06.005_bib15","doi-asserted-by":"crossref","first-page":"e1577125","DOI":"10.1080\/2162402X.2019.1577125","article-title":"Inhibition of urothelial carcinoma through targeted type I interferon-mediated immune activation","volume":"8","author":"Plote","year":"2019","journal-title":"Oncoimmunology"},{"key":"10.1016\/j.omto.2022.06.005_bib16","doi-asserted-by":"crossref","first-page":"1989","DOI":"10.1084\/jem.20101158","article-title":"Type I interferon is selectively required by dendritic cells for immune rejection of tumors","volume":"208","author":"Diamond","year":"2011","journal-title":"J.\u00a0Exp. Med."},{"key":"10.1016\/j.omto.2022.06.005_bib17","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1634\/theoncologist.7-1-46","article-title":"Adenoviral gene therapy","volume":"7","author":"Vorburger","year":"2002","journal-title":"Oncologist"},{"key":"10.1016\/j.omto.2022.06.005_bib18","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1152\/physiolgenomics.00069.2007","article-title":"Lentiviral vectors: are they the future of animal transgenesis?","volume":"31","author":"Park","year":"2007","journal-title":"Physiol. Genom."},{"key":"10.1016\/j.omto.2022.06.005_bib19","first-page":"1","article-title":"Viral vectors: a look back and ahead on gene transfer technology","volume":"36","author":"Vannucci","year":"2013","journal-title":"New Microbiol."},{"key":"10.1016\/j.omto.2022.06.005_bib20","doi-asserted-by":"crossref","first-page":"1233151","DOI":"10.1126\/science.1233151","article-title":"Lentiviral hematopoietic stem cell gene therapy in patients with Wiskott-Aldrich syndrome","volume":"341","author":"Aiuti","year":"2013","journal-title":"Science"},{"key":"10.1016\/j.omto.2022.06.005_bib21","doi-asserted-by":"crossref","first-page":"1233158","DOI":"10.1126\/science.1233158","article-title":"Lentiviral hematopoietic stem cell gene therapy benefits metachromatic leukodystrophy","volume":"341","author":"Biffi","year":"2013","journal-title":"Science"},{"key":"10.1016\/j.omto.2022.06.005_bib22","doi-asserted-by":"crossref","first-page":"318","DOI":"10.1038\/nature09328","article-title":"Transfusion independence and HMGA2 activation after gene therapy of human beta-thalassaemia","volume":"467","author":"Cavazzana-Calvo","year":"2010","journal-title":"Nature"},{"key":"10.1016\/j.omto.2022.06.005_bib23","doi-asserted-by":"crossref","first-page":"3954","DOI":"10.1158\/0008-5472.CAN-18-0173","article-title":"Molecular subtype-specific immunocompetent models of high-grade urothelial carcinoma reveal differential neoantigen expression and response to immunotherapy","volume":"78","author":"Saito","year":"2018","journal-title":"Cancer Res."},{"key":"10.1016\/j.omto.2022.06.005_bib24","doi-asserted-by":"crossref","first-page":"687","DOI":"10.1038\/sj.cgt.7700488","article-title":"Syn3 provides high levels of intravesical adenoviral-mediated gene transfer for gene therapy of genetically altered urothelium and superficial bladder cancer","volume":"9","author":"Yamashita","year":"2002","journal-title":"Cancer Gene Ther."},{"key":"10.1016\/j.omto.2022.06.005_bib25","doi-asserted-by":"crossref","first-page":"388","DOI":"10.1038\/nri3839","article-title":"Perforin and granzymes: function, dysfunction and human pathology","volume":"15","author":"Voskoboinik","year":"2015","journal-title":"Nat. Rev. Immunol."},{"key":"10.1016\/j.omto.2022.06.005_bib26","doi-asserted-by":"crossref","first-page":"201","DOI":"10.3201\/eid2402.171407","article-title":"Adenovirus type 4 respiratory infections among civilian adults, northeastern United States, 2011-2015(1)","volume":"24","author":"Kajon","year":"2018","journal-title":"Emerg. Infect. Dis."},{"key":"10.1016\/j.omto.2022.06.005_bib27","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1182\/blood-2013-01-306647","article-title":"Immune responses to AAV vectors: overcoming barriers to successful gene therapy","volume":"122","author":"Mingozzi","year":"2013","journal-title":"Blood"},{"key":"10.1016\/j.omto.2022.06.005_bib28","doi-asserted-by":"crossref","first-page":"717","DOI":"10.1016\/j.omtm.2020.03.025","article-title":"Development of large-scale downstream processing for lentiviral vectors","volume":"17","author":"Valkama","year":"2020","journal-title":"Mol. Ther. Methods Clin. Dev."},{"key":"10.1016\/j.omto.2022.06.005_bib29","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1016\/j.ymthe.2004.05.027","article-title":"Intravesical Ad-IFN\u03b1 causes marked regression of human bladder cancer growing orthotopically in nude mice and overcomes resistance to IFN-\u03b1 protein","volume":"10","author":"Benedict","year":"2004","journal-title":"Mol. Ther."},{"key":"10.1016\/j.omto.2022.06.005_bib30","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1146\/annurev-immunol-032713-120231","article-title":"Interferon-stimulated genes: a complex web of host defenses","volume":"32","author":"Schneider","year":"2014","journal-title":"Annu. Rev. Immunol."},{"key":"10.1016\/j.omto.2022.06.005_bib31","doi-asserted-by":"crossref","first-page":"887","DOI":"10.1083\/jcb.150.4.887","article-title":"Cross-talk between two cysteine protease families","volume":"150","author":"Nakagawa","year":"2000","journal-title":"J.\u00a0Cell Biol."},{"key":"10.1016\/j.omto.2022.06.005_bib32","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1038\/47513","article-title":"Caspase-12 mediates endoplasmic-reticulum-specific apoptosis and cytotoxicity by amyloid-\u03b2","volume":"403","author":"Nakagawa","year":"2000","journal-title":"Nature"},{"key":"10.1016\/j.omto.2022.06.005_bib33","first-page":"187","article-title":"Interferon-alpha reduces human hippocampal neurogenesis and increases apoptosis via activation of distinct STAT1-dependent mechanisms","volume":"21","author":"Borsini","year":"2018","journal-title":"Int. J. Neuro. psycho. pharmacol."},{"key":"10.1016\/j.omto.2022.06.005_bib34","doi-asserted-by":"crossref","first-page":"2102","DOI":"10.1038\/leu.2009.139","article-title":"IL-6, but not IFN-gamma, triggers apoptosis and inhibits in\u00a0vivo growth of human malignant T\u00a0cells on STAT3 silencing","volume":"23","author":"Regis","year":"2009","journal-title":"Leukemia"},{"key":"10.1016\/j.omto.2022.06.005_bib35","doi-asserted-by":"crossref","first-page":"6623","DOI":"10.1158\/0008-5472.CAN-08-0463","article-title":"Sensitization to the lysosomal cell death pathway by oncogene-induced down-regulation of lysosome-associated membrane proteins 1 and 2","volume":"68","author":"Fehrenbacher","year":"2008","journal-title":"Cancer Res."},{"key":"10.1016\/j.omto.2022.06.005_bib36","doi-asserted-by":"crossref","first-page":"6","DOI":"10.4049\/jimmunol.167.1.6","article-title":"Cutting edge: ly49A inhibits TCR\/CD3-induced apoptosis and IL-2 secretion","volume":"167","author":"Roger","year":"2001","journal-title":"J.\u00a0Immunol."},{"key":"10.1016\/j.omto.2022.06.005_bib37","doi-asserted-by":"crossref","first-page":"11002","DOI":"10.1073\/pnas.93.20.11002","article-title":"Activation of an interleukin 1 converting enzyme-dependent apoptosis pathway by granzyme B","volume":"93","author":"Shi","year":"1996","journal-title":"Proc. Natl. Acad. Sci. U\u00a0S\u00a0A."},{"key":"10.1016\/j.omto.2022.06.005_bib38","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1093\/intimm\/dxn132","article-title":"IL-23 modulates CD56+\/CD3- NK cell and CD56+\/CD3+ NK-like T\u00a0cell function differentially from IL-12","volume":"21","author":"van de Wetering","year":"2009","journal-title":"Int. Immunol."},{"key":"10.1016\/j.omto.2022.06.005_bib39","doi-asserted-by":"crossref","first-page":"518","DOI":"10.21037\/atm.2016.11.82","article-title":"Aldehyde dehydrogenases in cancer stem cells: potential as therapeutic targets","volume":"4","author":"Clark","year":"2016","journal-title":"Ann. Transl Med."},{"key":"10.1016\/j.omto.2022.06.005_bib40","doi-asserted-by":"crossref","first-page":"669","DOI":"10.1016\/j.biopha.2013.04.005","article-title":"The role of aldehyde dehydrogenase (ALDH) in cancer drug resistance","volume":"67","author":"Januchowski","year":"2013","journal-title":"Biomed. Pharmacother."},{"key":"10.1016\/j.omto.2022.06.005_bib41","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1007\/s11523-015-0357-x","article-title":"The route to personalized medicine in bladder cancer: where do we stand?","volume":"10","author":"Massari","year":"2015","journal-title":"Target. Oncol."},{"key":"10.1016\/j.omto.2022.06.005_bib42","doi-asserted-by":"crossref","first-page":"402","DOI":"10.1006\/meth.2001.1262","article-title":"Analysis of relative gene expression data using real-time quantitative PCR and the 2\u2212\u0394\u0394CT method","volume":"25","author":"Livak","year":"2001","journal-title":"Methods"},{"key":"10.1016\/j.omto.2022.06.005_bib43","doi-asserted-by":"crossref","first-page":"1236","DOI":"10.1093\/bioinformatics\/btg148","article-title":"Estimating the occurrence of false positives and false negatives in microarray studies by approximating and partitioning the empirical distribution of p-values","volume":"19","author":"Pounds","year":"2003","journal-title":"Bioinformatics"},{"key":"10.1016\/j.omto.2022.06.005_bib44","doi-asserted-by":"crossref","first-page":"27455","DOI":"10.1038\/srep27455","article-title":"Local immune stimulation by intravesical instillation of baculovirus to enable bladder cancer therapy","volume":"6","author":"Ang","year":"2016","journal-title":"Sci. Rep."},{"key":"10.1016\/j.omto.2022.06.005_bib45","doi-asserted-by":"crossref","first-page":"4515","DOI":"10.1158\/0008-5472.CAN-13-3275","article-title":"\u03b2-Catenin activation in a novel liver progenitor cell type is sufficient to cause hepatocellular carcinoma and hepatoblastoma","volume":"74","author":"Mokkapati","year":"2014","journal-title":"Cancer Res."}],"container-title":["Molecular Therapy - Oncolytics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2372770522000833?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2372770522000833?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,7]],"date-time":"2025-11-07T06:23:39Z","timestamp":1762496619000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2372770522000833"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,9]]},"references-count":45,"alternative-id":["S2372770522000833"],"URL":"https:\/\/doi.org\/10.1016\/j.omto.2022.06.005","relation":{},"ISSN":["2372-7705"],"issn-type":[{"value":"2372-7705","type":"print"}],"subject":[],"published":{"date-parts":[[2022,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Lentiviral interferon: A novel method for gene therapy in bladder cancer","name":"articletitle","label":"Article Title"},{"value":"Molecular Therapy - Oncolytics","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.omto.2022.06.005","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 The Author(s).","name":"copyright","label":"Copyright"}]}}